| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.41 | 0.04 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.13 | 0.05 |